| 摘要 |
The invention includes a novel therapeutic agent comprising 4-(4-chlorophenylsulphonylcarbamoyl)benzoyl-L-valyl-L-proline 1(RS)-(1-trifluoroacetyl-2methylpropyl)amide for use in the prevention or treatment of haemorrhagic conditions associated with acute non-lymphocytic leukaemia or its therapy, the use of this peptide derivative in the manufacture of a medicament for the prevention or treatment of said haemorrhagic conditions, as well as a method of prevention or treatment of said haemorrhagic conditions, as well as a method of prevention or treatment of said haemorrhagic conditions using the peptide derivative. |
